Pelzer, Florian http://orcid.org/0000-0002-8169-4539
Tröger, Wilfried
Reif, Marcus
Schönberg, Susanne
Martin, David D.
Müller, Cornelia
Utz-Billing, Isabell
Kühn, Thorsten
Baumgartner, Stephan
Kiechle, Marion
Paepke, Daniela
Clinical trials referenced in this document:
Documents that mention this clinical trial
Fatigue and quality of life during neoadjuvant chemotherapy of early breast cancer: a prospective multicenter cohort study
https://doi.org/10.1007/s12282-023-01520-y
Funding for this research was provided by:
Society for Cancer Research, Arlesheim, Switzerland
Gesellschaft für klinische Forschung e.V., Berlin. Germany
Private Universität Witten/Herdecke gGmbH
Article History
Received: 3 July 2023
Accepted: 22 October 2023
First Online: 15 November 2023
Declarations
:
: The nonprofit organizations Society for Cancer Research and Gesellschaft für klinische Forschung e.V. are minority shareholders of Iscador AG, a manufacturer of mistletoe extracts, which are being used for supportive care in oncology. No products of Iscador AG were investigated in the current study. FP, WT, MR, SS and SB are or have been employed by Iscador AG during at least some part of the study. MK has received remuneration from Springer Press, Biermann Press, Celgene, AstraZeneca, Myriad Genetics, TEVA, Eli Lilly GSK, Seagen, received consultancy or advisory fees from Myriad Genetics, Bavarian KVB, DKMS Life, BLÄK, TEVA and exeltis, holds stock in Therawis Diagnostics GmbH and AIM GmbH and received funding from Sphingotec, Deutsche Krebshilfe, DFG, BMBF, Bavarian State Ministry of Economy, Innovation Fond GBA, the Senator Roesner Foundation and the Dr Pommer-Jung Foundation. TK has received honoraria from Merck Sharp & Dohme, Astra Zeneca, Pfizer, Gilead, Daiichi Sankyo, Endomag, Sirius medical, Hologic, Merit Medical and received support for attending meetings from Daiichi Sankyo. DP received honoraria from Seagen, Gilead, Iscador AG, Kneipp Ärztebund and holds an unpaid leadership role in the AGO Kommission Integrative Medizin. CM, DDM, IUB have no conflict of interest.
: The study was conducted in accordance with the Declaration of Helsinki (October 2013) and approved by the Ethics Committees of the Technical University of Munich and of the State Medical Chambers of Baden-Württemberg and Brandenburg. The Ethics Committee of the State Medical Chambers of Berlin declined to assess the study because Ethics Committee approval had already been granted.
: Informed consent to participate was obtained from all individual participants included in the study.
: Informed consent for publication was obtained from all individual participants included in the study.